NVP-BAW2881
Product Specifications
UNSPSC Description
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR2 inhibitor with an IC50 of 4 nM.
Target Antigen
Tie; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Endocrinology; Cancer
Assay Protocol
https://www.medchemexpress.com/NVP-BAW2881.html
Purity
98.54
Solubility
DMSO : ≥ 33 mg/mL
Smiles
O=C(C1=C2C=CC(OC3=NC(N)=NC=C3)=CC2=CC=C1)NC4=CC=CC(C(F)(F)F)=C4
Molecular Weight
424.38
References & Citations
[1]Bold G, et al. A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis. J Med Chem. 2016 Jan 14;59(1):132-46.|[2]Halin C, et al. Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. Am J Pathol. 2008 Jul;173(1):265-77.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-100394/NVP-BAW2881-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-100394/NVP-BAW2881-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
861875-60-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CSB-EP347478THA-01 20 µg
Recombinant Toxocara canis 26KDA secreted antigen (TES-26)
Ask
View Details CSB-EP347478THA-02 100 µg
Recombinant Toxocara canis 26KDA secreted antigen (TES-26)
Ask
View Details 
